-
Rheumatoid Arthritis Drugs Market Size to Worth USD 27.38 Bn by 2033
22 Mar 2024 15:05 GMT
… )
Biosimilar
Rheumatoid Arthritis, Polyarticular Juvenile idiopathic Arthritis, Systemic Juvenile Idiopathic Arthritis
These new … . Recent Developments
In July 2023, Biocon Biologics Ltd, a part of …
-
Cytokine Market Is Booming Worldwide 2024-2031 | Biocon Limited, Johnson & Johnson, Abbvie Inc.
22 Mar 2024 06:22 GMT
… companies in Cytokine Market are: Biocon Limited, Johnson & Johnson, Abbvie … : Cancer, Asthma and Airway Inflammation, Arthritis, and Other Therapeutic Applications
Market …
-
Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
01 Mar 2024 04:57 GMT
… a fully integrated biosimilars company, Biocon Biologics is committed to expanding … Chief Commercial Officer – Advanced Markets, Biocon Biologics Ltd, said: “This agreement … colitis, plaque psoriasis and psoriatic arthritis. The reference brand, Stelara®, …
-
With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US
29 Feb 2024 19:51 GMT
… ;s sales pie.
Thursday, Biocon Biologics said it has inked … J. With the deal, Biocon Biologics has secured a license … Patent and Trademark Office.
Biocon joins several other biosimilar players … S. are plaque psoriasis, psoriatic arthritis, Crohn's disease …
-
Biocon Biologics inks licence pact with Janssen for biosimilar product
29 Feb 2024 16:46 GMT
… and Drug Administration(USFDA), Biocon Biologics said in a … is a subsidiary of Biocon Ltd.
Biocon Biologics and Janssen … stated.
This development enables Biocon Biologics to build further … , plaque psoriasis and psoriatic arthritis.
(You can now subscribe …
-
Biocon Biologics Secures US Market Entry Date for Bmab 1200, a Proposed Biosimilar to Stelara®
29 Feb 2024 15:22 GMT
… colitis, plaque psoriasis and psoriatic arthritis. The reference brand, Stelara®, … their respective owners.
About Biocon Biologics Limited: Biocon Biologics Ltd. (BBL), … Twitter: @BioconBiologics for company updates.
Biocon Limited, publicly listed in 2004 …
-
Latest News | Biocon Biologics Inks Licence Pact with Janssen for Biosimilar Product
29 Feb 2024 15:18 GMT
… and Drug Administration(USFDA), Biocon Biologics said in a … Mode; Check Other Details.
Biocon Biologics and Janssen have … stated.
This development enables Biocon Biologics to build further … , plaque psoriasis and psoriatic arthritis.
(This is an unedited …
-
Millions of arthritis patients could struggle to get blockbuster drug, as CVS pulls it from pharmacies
04 Jan 2024 18:23 GMT
… in adults, such as rheumatoid arthritis, psoriatic arthritis and plaque psoriasis, among … the pain associated with rheumatoid arthritis.
Swiss drugmaker Sandoz is supplying … well as Indian pharmaceutical company Biocon.
Although nine Humira biosimilars were …
-
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan
23 Dec 2023 08:15 GMT
… -related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, … ," the release stated.
Biocon Biologics recently announced the successful … immunology, and ophthalmology.
Read also: Biocon arm completes integration of Viatris …
-
Biocon Biologics partners with Sandoz for distribution of Adalimumab biosimilar in Japan
22 Dec 2023 18:47 GMT
… marketing license agreement with Biocon Biologics Ltd affiliate.
Adalimumab … related diseases such as rheumatoid arthritis, psoriasis vulgaris, ankylosing spondylitis, … immunology and biosimilar portfolio.
Biocon Biologics recently announced the successful …